"Tayada aad ugu horraysa, Daacadnimo saldhig ahaan, Gargaar daacad ah iyo faa'iido wadaag" waa fikraddayada, dadaalka aan ku abuureyno si joogto ah oo aan u daba galno heerka ugu sarreeya ee Qiimaha tartanka ee Warshada Jumladda Organic Intermediate BMK Pmk Powder 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino] - CAS 22563-90-2, Tayada sare waxay noqon doontaa qodobka ugu muhiimsan ee ururkaas si uu uga soo baxo tartamayaasha kale.Aragtidu waa Rumayn, ma doonaysaa macluumaad dheeraad ah?Kaliya tijaabi alaabteeda!
"Tayada marka hore, Daacadnimo saldhig u ah, Gargaar daacad ah iyo faa'iido wadaag" waa fikraddayada, dadaalka aan ugu jirno inaan si joogto ah u abuurno oo aan u raadinno heerka ugu sarreeyaDhexdhexaadiyeyaasha Dawooyinka ee Shiinaha iyo Dhexdhexaadiyeyaasha Agrochemical, Si aad u hesho macluumaad dheeraad ah oo nagu saabsan iyo sidoo kale u aragto dhammaan baayacmushtarka, fadlan booqo website-kayaga.Si aad u hesho macluumaad dheeraad ah fadlan xor u noqo inaad noo ogolaato inaan ogaano.Aad baad u mahadsantahay oo u rajaynaya in ganacsigaagu had iyo jeer ahaado mid wanaagsan!
3'-Amino-2'-hydroxy-[1,1'-bipheny]-3-carboxylic acid waxaa loo isticmaalaa dhexdhexaadka Eltrombopag.
Eltrombopag, oo ay soo saartay GlaxoSmithKline (GSK) ee UK oo markii dambe si wadajir ah ula sameeyay Novartis ee Switzerland, waa kan ugu horreeya oo kaliya ee la ansixiyay molecule yar yar oo aan peptide TPO receptor agonist ee adduunka.Eltrombopag waxaa ansixiyay US FDA 2008 si loogu daweeyo idiopathic thrombocytopenic purpura (ITP), iyo 2014 ee daawaynta aplastic anemia daran (AA).Sidoo kale waa dawadii ugu horeysay ee ay ogolaato FDA US daawaynta AA 30kii sano ee la soo dhaafay.
Bishii Disembar 2012, US FDA waxay ansixisay Eltrombopag daaweynta thrombocytopenia ee bukaannada qaba cagaarshow C dabadheeraad ah (CHC), si bukaannada cagaarshowga C ee qaba saadaasha liidata sababtoo ah tirinta platelet hoose waxay bilaabi karaan oo ay ilaalin karaan interferon ku salaysan daaweynta caadiga ah ee cudurada beerka.Febraayo 3,2014, GlaxoSmithKline waxay ku dhawaaqday in FDA ay siisay shahaadada daawaynta dawaynta ee Eltrombopag ee daawaynta hemopenia ee bukaanada qaba buuga kiimikada daran aplastic anemia (SAA) kuwaas oo aan si buuxda uga jawaabin tallaalka.Agoosto 24, 2015, US FDA waxay ansixisay Eltrombopag daaweynta thrombocytopenia ee dadka waaweyn iyo carruurta da'doodu tahay 1 sano iyo ka weyn ee leh difaaca difaaca joogtada ah ee thrombocytopenia (ITP) kuwaas oo aan lahayn jawaab celin ku filan corticosteroids, immunoglobulins ama splenectomy.Janaayo 4, 2018, Eltrombopag waxaa loo ogolaaday in lagu daro Shiinaha si loogu daaweeyo trombocytopenia difaaca aasaasiga ah (ITP).
"Tayada aad ugu horraysa, Daacadnimo saldhig ahaan, Gargaar daacad ah iyo faa'iido wadaag" waa fikraddayada, dadaalka aan ku abuureyno si joogto ah oo aan u daba galno heerka ugu sarreeya ee Qiimaha tartanka ee Warshada Jumladda Organic Intermediate BMK Pmk Powder 1-Propanol, 2-Methyl-2- [(phenylmethylene) Amino] - CAS 22563-90-2, Tayada sare waxay noqon doontaa qodobka ugu muhiimsan ee ururkaas si uu uga soo baxo tartamayaasha kale.Aragtidu waa Rumayn, ma doonaysaa macluumaad dheeraad ah?Kaliya tijaabi alaabteeda!
Qiimaha tartanka loogu jiroDhexdhexaadiyeyaasha Dawooyinka ee Shiinaha iyo Dhexdhexaadiyeyaasha Agrochemical, Si aad u hesho macluumaad dheeraad ah oo nagu saabsan iyo sidoo kale u aragto dhammaan baayacmushtarka, fadlan booqo website-kayaga.Si aad u hesho macluumaad dheeraad ah fadlan xor u noqo inaad noo ogolaato inaan ogaano.Aad baad u mahadsantahay oo u rajaynaya in ganacsigaagu had iyo jeer ahaado mid wanaagsan!